These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 30474757

  • 1. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J, Wu N, Lv C, Yan S, Yang Y.
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [Abstract] [Full Text] [Related]

  • 2. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D, Bozcuk H, Gunduz S, Tural D, Tattli AM, Uysal M, Goksu SS, Bassorgun Cİ, Koral L, Coskun HS, Ozdogan M, Savas B.
    Asian Pac J Cancer Prev; 2014 Feb; 15(6):2465-72. PubMed ID: 24761848
    [Abstract] [Full Text] [Related]

  • 3. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
    Zhang P, Duan J, Bai H, Wang Z, Gao S, Tan F, Gao Y, Wang X, Wan R, Xu J, He X, Feng X, Yu R, Sun J, Zhao Z, Fei K, Li N, He J, Wang J.
    Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patients treated with platinum-doublet chemotherapy for advanced non--small-cell lung cancer have inferior outcomes if previously treated with platinum-based chemoradiation.
    Paramanathan A, Solomon B, Collins M, Franco M, Kofoed S, Francis H, Ball D, Mileshkin L.
    Clin Lung Cancer; 2013 Sep; 14(5):508-12. PubMed ID: 23792009
    [Abstract] [Full Text] [Related]

  • 8. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
    Kubota K, Sakai H, Katakami N, Nishio M, Inoue A, Okamoto H, Isobe H, Kunitoh H, Takiguchi Y, Kobayashi K, Nakamura Y, Ohmatsu H, Sugawara S, Minato K, Fukuda M, Yokoyama A, Takeuchi M, Michimae H, Gemma A, Kudoh S, Tokyo Cooperative Oncology Group.
    Ann Oncol; 2015 Jul; 26(7):1401-8. PubMed ID: 25908605
    [Abstract] [Full Text] [Related]

  • 9. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
    Abdel-Rahman O.
    Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
    [Abstract] [Full Text] [Related]

  • 10. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
    Dediu M, Ion O, Ion R, Alexandru A, Median D, Gal C, Horvat T, Motas C, Motas N.
    J BUON; 2012 Nov; 17(2):317-22. PubMed ID: 22740212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lung cancer in women, a different disease: survival differences by sex in Turkey.
    Ulas A, Tokluoglu S, Kos M, Silay K, Akinci S, Oksuzoglu B, Alkis N.
    Asian Pac J Cancer Prev; 2015 Nov; 16(2):815-22. PubMed ID: 25684531
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J, Zhang X, Hu S, Peng WD, Xu B, Li Y, Zhang SJ, Li Q, Li C.
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Efficacy between Pemetrexed plus Platinum and Non-Pemetrexed plus Platinum as First-Line Treatment in Patients with Wild-Type Epidermal Growth Factor Receptor Nonsquamous Non-Small Cell Lung Cancer: A Retrospective Analysis.
    Kang EJ, Min KH, Hur GY, Lee SY, Shim JJ, Kang KH, Oh SC, Seo JH, Kim JS.
    Chemotherapy; 2016 Sep; 61(1):41-50. PubMed ID: 26517706
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and survival-associated factors with gefitinib combined with cisplatin and gemcitabine for advanced non- small cell lung cancer.
    Fang H, Lin RY, Sun MX, Wang Q, Zhao YL, Yu JL, Tian Y, Wang XY.
    Asian Pac J Cancer Prev; 2014 Sep; 15(24):10967-70. PubMed ID: 25605210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.